Pulmonary Function Reference Equations: A Brief History to Explain All the Confusion

References

1. 1.↵
   1. Poirier KP

   . A quantitative definition of obstructive lung disease. Am J Med 1968;45(3):329-335.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Spriggs EA

   . John Hutchinson, the inventor of the spirometer - his north country background, life in London, and scientific achievements. Med Hist 1977;21(4):357-364.

   OpenUrlPubMed
3. 3.↵
   1. Kory RC,
   2. Callahan R,
   3. Boren HG,
   4. Syner JC

   . The Veterans Administration-Army cooperative study of pulmonary function. I. Clinical spirometry in normal men. Am J Med 1961;30(2):243-258.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Morris JF,
   2. Koski A,
   3. Johnson LC

   . Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971;103(1):57-67.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Bates J

   . Lung mechanics, an inverse modeling approach. New York: Cambridge University Press; 2009:9-11.
6. 6.↵
   1. Petty TL

   . John Hutchinson’s mysterious machine revisited. Chest 2002;121(5 Suppl):219S-223S.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Quanjer PH,
   2. Stanojevic S,
   3. Cole TJ,
   4. Baur X,
   5. Hall GL,
   6. Culver BH,
   7. et al

   . Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324-1343.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Stanojevic S,
   2. Cole TJ,
   3. Stocks J,
   4. Quanjer PH

   . Disentangling the discordance between epidemiological associations and physiological mechanisms. Thorax 2014;69(9):869.

   OpenUrlFREE Full Text
9. 9.↵
   1. Haynes JM,
   2. Stumbo RW

   . The impact of using non-birth sex on the interpretation of spirometry data in subjects with air-flow obstruction. Respir Care 2018;63(2):215-218.

   OpenUrlAbstract/FREE Full Text
10. 10.
    1. Quanjer PH,
    2. Hall GL,
    3. Stanojevic S,
    4. Cole TJ,
    5. Stocks J

    . Age-and height-based prediction bias in spirometry reference equations. Eur Respir J 2012;40(1):190-197.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Quanjer PH,
    2. Stocks J,
    3. Cole TJ,
    4. Hall GL,
    5. Stanojevic S

    . Influence of secular trends and sample size on reference equations for lung function tests. Eur Respir J 2011;37(3):658-664.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Stanojevic S,
    2. Wade A,
    3. Stocks J

    . Reference values for lung function: past, present and future. Eur Respir J 2010;36(1):12-19.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Miller MR,
    2. Quanjer PH,
    3. Swanney MP,
    4. Ruppel G,
    5. Enright PL

    . Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011;139(1):52-59.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Stanojevic S,
    2. Graham BL,
    3. Cooper BG,
    4. Thompson BR,
    5. Carter KW,
    6. Francis RW,
    7. et al

    . Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J 2017;50(3):1700010.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Culver BH,
    2. Graham BL,
    3. Coates AL,
    4. Wanger J,
    5. Berry CE,
    6. Clarke PK,
    7. et al

    . Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement. Am J Respir Crit Care Med 2017;196(11):1463-1472.

    OpenUrl
16. 16.↵
    1. Miller MR,
    2. Levy ML

    . Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ 2015;351:h3021.

    OpenUrlFREE Full Text
17. 17.↵
    1. Akkermans RP,
    2. Berrevoets MA,
    3. Smeele IJ,
    4. Lucas AE,
    5. Thoonen BP,
    6. Grootens-Stekelenburg JG,
    7. et al

    . Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med 2012;12:12.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Crapo RO,
    2. Jensen RL

    . Standards and interpretive issues in lung function testing. Respir Care 2003;48(8):764-772.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Perez-Padilla R,
    2. Wehrmeister FC,
    3. de Oca MM,
    4. Lopez MV,
    5. Jardim JR,
    6. Muiño A,
    7. et al

    . Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort. Int J Chron Obstruct Pulmon Dis 2018;13:3549-3561.

    OpenUrl
20. 20.
    1. Wang C,
    2. Xu J,
    3. Yang L,
    4. Xu Y,
    5. Zhang X,
    6. Bai C,
    7. et al

    . Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018;391(10131):1706-1717.

    OpenUrlCrossRefPubMed
21. 21.
    1. Hangaard S,
    2. Kronborg T,
    3. Hejlesen OK

    . Characteristics of subjects with undiagnosed COPD based on post-bronchodilator spirometry data. Respir Care 2019;64(1):63-70.

    OpenUrlAbstract/FREE Full Text
22. 22.
    1. Ronaldson SJ,
    2. Dyson L,
    3. Clark L,
    4. Hewitt CE,
    5. Torgerson DJ,
    6. Cooper BG,
    7. et al

    . Determining the optimal approach to identifying individuals with chronic obstructive pulmonary disease: The DOC study. J Eval Clin Pract 2018;24(3):487-495.

    OpenUrl
23. 23.↵
    1. Bellamy D,
    2. Bouchard J,
    3. Henrichsen S,
    4. Johansson G,
    5. Langhammer A,
    6. Reid J,
    7. et al

    . International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 2006;15(1):48-57.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Hardie JA,
    2. Buist AS,
    3. Vollmer WM,
    4. Ellingsen I,
    5. Bakke PS,
    6. Mørkve O

    . Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20(5):1117-1122.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Vaz Fragoso CA,
    2. Concato J,
    3. McAvay G,
    4. Van Ness PH,
    5. Rochester CL,
    6. Yaggi HK,
    7. et al

    . The ratio of FEV₁ to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(5):446-451.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Cerveri I,
    2. Corsico AG,
    3. Accordini S,
    4. Niniano R,
    5. Ansaldo E,
    6. Antó JM,
    7. et al

    . Underestimation of airflow obstruction among young adults using FEV₁/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008;63(12):1040-1045.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Mannino DM,
    2. Buist AS,
    3. Vollmer WM

    . Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62(3):237-241.

    OpenUrlAbstract/FREE Full Text
28. 28.
    1. Hoesein FA,
    2. Zanen P,
    3. Lammers JW

    . Lower limit of normal or FEV₁/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105(6):907-915.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Garcia-Aymerich J,
    2. Serra Pons I,
    3. Mannino DM,
    4. Maas AK,
    5. Miller DP,
    6. Davis KJ

    . Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax 2011;66(7):585-590.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Vaz Fragoso CA,
    2. Concato J,
    3. McAvay G,
    4. Van Ness PH,
    5. Rochester CL,
    6. Yaggi HK,
    7. et al

    . Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010;104(8):1189-1196.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Bridevaux PO,
    2. Gerbase MW,
    3. Probst-Hensch NM,
    4. Schindler C,
    5. Gaspoz JM,
    6. Rochat T

    . Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008;63(9):768-774.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Celli BR,
    2. Halbert RJ

    . Point: should we abandon FEV₁/FVC <0.70 to detect airway obstruction? No. Chest 2010;138(5):1037-1040.

    OpenUrlCrossRefPubMed
33. 33.
    1. Enright P,
    2. Brusasco V

    . Counterpoint: should we abandon FEV₁/FVC <0.70 to detect airway obstruction? Yes. Chest 2010;138(5):1040-1042.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Bhatt SP,
    2. Balte PP,
    3. Schwartz JE,
    4. Cassano PA,
    5. Couper D,
    6. Jacobs DR Jr.,
    7. et al

    . Discriminative accuracy of FEV₁:FVC thresholds for COPD-related hospitalization and mortality. JAMA 2019;321(24):2438-2447.

    OpenUrl
35. 35.↵
    1. Mannino DM

    . Should we be using statistics to define disease? Thorax 2008;63(12):1031-1032.

    OpenUrlFREE Full Text
36. 36.↵
    1. Bhatt SP,
    2. Sieren JC,
    3. Dransfield MT,
    4. Washko GR,
    5. Newell JD,
    6. Stinson DS,
    7. et al

    . Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax 2014;69(5):409-414.

    OpenUrlPubMedWeb of Science
37. 37.↵
    1. Lutchmedial SM,
    2. Creed WG,
    3. Moore AJ,
    4. Walsh RR,
    5. Gentchos GE,
    6. Kaminsky DA

    . How common is airflow limitation in patients with emphysema on CT scan of the chest? Chest 2015;148(1):176-184.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Gemicioglu B,
    2. Musellim B,
    3. Dogan I,
    4. Guven K

    . Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes. Allergy Rhinol (Providence) 2014;5(3):157-161.

    OpenUrl
39. 39.↵
    1. Güder G,
    2. Brenner S,
    3. Angermann CE,
    4. Ertl G,
    5. Held M,
    6. Sachs AP,
    7. et al

    . GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res 2012;13(1):13.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Topalovic M,
    2. Laval S,
    3. Aerts J-M,
    4. Troosters T,
    5. Decramer M,
    6. Janssens W

    . Automated interpretation of pulmonary function tests in adults with respiratory complaints. Respiration 2017;93(3):170-178.

    OpenUrl
41. 41.↵
    1. Berry CE,
    2. Billheimer D,
    3. Jenkins IC,
    4. Lu ZJ,
    5. Stern DA,
    6. Gerald LB,
    7. et al

    . A distinct low lung function trajectory from childhood to the fourth decade of life. Am J Respir Crit Care Med 2016;194(5):607-612.

    OpenUrl
42. 42.↵
    1. Krishnan JK,
    2. Martinez FJ

    . Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps. Curr Opin Pulm Med 2018;24(2):124-129.

    OpenUrl
43. 43.↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB

    . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159(1):179-187.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Pellegrino R,
    2. Viegi G,
    3. Brusasco V,
    4. Crapo RO,
    5. Burgos F,
    6. Casaburi R,
    7. et al

    . Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.

    OpenUrlFREE Full Text